DNA Sequencing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Consumable, Instruments, and Others), By Sequencing Type (Sanger Sequencing, Next Generation Sequencing, and Others), By End Users (Hospitals, Academic Research, Clinical Research, and Clinics), and Region Forecast 2019 - 2030

DNA Sequencing Market size was valued at USD 10.7 billion in 2023 and is expected to grow at a CAGR of 12.2% from 2024 - 2030. the forecast period. The sequences of the bases {adenine (A), cytosine (C), guanine (G), and thymine (T)} in a DNA molecule can be ascertained by a laboratory procedure called DNA sequencing. The DNA that needs to be sequenced is prepared in a sample. The polymerase chain reaction (PCR) is subsequently used to amplify the target sequence. The amplicons are then carefully purified, and the DNA sequencing procedures are initiated. After the DNA is sequenced, the necessary data is obtained and examined.

The National Human Genome Research Institute (NHGRI) has announced that the genetic makeup of all humans is 99.9% the same. DNA sequencing is used to investigate the remaining 0.1% to identify the disorders' underlying causes. Numerous fields, including molecular biology, evolutionary biology, metagenomics, virology, medicine, and forensic investigations, have found extensive uses for this technique. the continuous evolution of genome sequencing technology has revolutionized the genomics field and is widespread across the healthcare industry.

Moreover, technological advancements have resulted in sizeable improvements in sequencing speed. these platforms employ parallel processing enabling the simultaneous analysis of multiple DNA fragments. This acceleration in speed has far-reaching implications, allowing researchers and clinicians to process large volumes of genomic data more efficiently than ever. For instance, in March 2023 Illumina, Inc. unveiled its connected insights base software designed to facilitate tertiary analysis for clinical NGS data. Such initiatives are expected to drive the market growth in forecasting years. Overall technological advancement continues to straighten out the complexity of the human genome, Researchers, and health care professionals are increasingly turning to DNA sequencing to obtain valuable insights that have transformative implications for medical diagnosis, treatment, and disease prevention.        

 DNA Sequencing Market Key Developments:

• In November 2023: Illumina, Inc. launched its global health access initiative to support access to public health sequencing tools in low and middle-income countries
• In August 2023: PacBio agreed to acquire Apton Biosystem. This acquisition is anticipated to accelerate the development of a short-read sequencer, propelling the market growth